Agenus

AGENNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$290.391 M

$6.43 -7.75%

Close of 6 Nov 2026

As of 6 Nov 2026, Agenus (AGEN) has a market capitalization of $290.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$114.2M

#2445 by revenue

Earnings

-$3.08M

Loss-making

Shares outstanding

45,246,510

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#82AlectorALEC$310.6M
#83Scribe TherapeuticsSCTX$293.7M
#84AgenusAGEN$290.4M
#85Kyverna TherapeuticsKYTX$284.8M
#86OcugenOCGN$276.5M

What if Agenus were worth as much as…

Open the what-if tool →

Gold $28.2T

$625,236.40

Per share 97,237× higher

Bitcoin $1.53T

$33,830.45

Per share 5,261× higher

Apple $5.02T

$111,062.22

Per share 17,273× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Agenus are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.